Search clinical trials for: AGN-151586

Total 129 results

Allergan

Completed

A Study to Assess Safety and Efficacy in Participants Age 40 to 55 With Presbyopia (Old Eye) Who Receive AGN-190584 in Both Eyes Twice Daily (Virgo)

Presbyopia

United States
Allergan

Completed

AGN-229666 Ophthalmic Solution for the Treatment of Seasonal or Perennial Allergic Conjunctivitis

Conjunctivitis, Allergic

Japan
AbbVie

Recruiting

AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-angle Glaucoma

United States, Japan
AbbVie

Terminated

Phase 1/2 Study of AGN-241622 in Healthy Participants and Participants With Presbyopia

Presbyopia

United States
AbbVie

Recruiting

Study of Cariprazine Oral Capsules or Solution to Assess Adverse Events and Change in Irritability Due to Autism Spectrum Disorder (ASD) in Participants Aged 5-17 Years With ASD

Autism Spectrum Disorder

United States, Puerto Rico
Tulane University
Patient-Centered Outcomes Research Institute

Recruiting

The Allergen Reduction and Child Health Study (ARCHS) (ARCHS)

Asthma in Children

United States
Allergan

Completed

Study to Assess Adverse Events (AEs) When Oral Atogepant Tablet is Given to Adult Chinese Participants Who Completed Study 3101-303-002 to Prevent Chronic Migraine

Chronic Migraine

China
AbbVie

Not yet recruiting

A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative Colitis

Ulcerative Colitis (UC)

United States, Puerto Rico
AbbVie
Ironwood Pharmaceuticals, Inc.

Recruiting

A Study to Assess Adverse Events and Change in Symptoms With Linaclotide Versus Placebo in Pediatric Subjects, Ages 2 to 5 Years, With Functional Constipation

Functional Constipation (FC) | Chronic Idiopathic Constipation (CIC)

United States, United Kingdom, Bulgaria, Netherlands
Allergan

Completed

Safety and Pharmacokinetics of Abicipar Pegol Intravitreal Injections in Japanese Patients With Neovascular AMD (PINE)

Macular Degeneration

Japan
Allergan

Completed

Safety and Pharmacodynamics Study of AGN-207281 Ophthalmic Solutions Compared With Timolol Ophthalmic Solution or Placebo in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma

Ocular Hypertension | Glaucoma, Open-Angle

United States
Allergan

Completed

AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis

Conjunctivitis, Allergic

Japan
AbbVie

Available

Expanded Access to Bimatoprost (Durysta)

Open-angle Glaucoma
Allergan

Completed

Safety and Efficacy of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma, Open-Angle

United States
Allergan

Completed

A Study of Armour® Thyroid Compared to Synthetic T4 (Levothyroxine) in Previously Hypothyroid Participants

Hypothyroidism | Thyroid Disease | Euthyroid | Thyroid Gland | Thyroid Hormones

United States
Sameem M. Abedin, MD

Recruiting

Neihulizumab for Standard-Risk Acute Graft Versus Host Disease (GVHD)

Graft-versus-host Disease

United States
AgNovos Healthcare, LLC

Recruiting

RECONFIRM - Study of AGN1 LOEP in Patients With Osteoporosis

Osteoporosis

Belgium
Algernon Pharmaceuticals
Centre for Human Drug Research, Netherlands

Active, not recruiting

Single and Repeat Doses of DMT in Healthy Subjects

Stroke

Netherlands
AgNovos Healthcare, LLC
Avania; BioClinica, Inc.; CMIC Co, Ltd. Japan; Emergent Clinical Consulting, LLC

Recruiting

RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures

Hip Fractures | Osteoporosis | Fragility Fracture

Denmark, Spain, Netherlands, France, Germany, Japan, Italy, Austria, United Kingdom
Allergan

Completed

Safety, Tolerability and Pharmacokinetics of AGN-190168 in Subjects With Acne Vulgaris

Acne Vulgaris

United States
Milton S. Hershey Medical Center

Active, not recruiting

Angelica Gigas Dietary Supplements and Human Immune Cells

Innate Immune Cells

United States
Allergan

Completed

Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD)

Age-related Macular Degeneration

United States, Italy, Australia, Israel, Germany, Austria, France, Switzerland
AbbVie

Recruiting

An Observational Study to Assess Next Generation Emulsion Preservative Free Eye Drops (NGE-UD) on Dry Eye Symptoms and Quality of Life of Adult Participants With Mild to Moderate Dry Eye Disease (DED)

Dry Eye

United States
AgNovos Healthcare, LLC

Completed

GRACE - Study of AGN1 LOEP in Osteopenic and Osteoporotic Patients

Osteoporosis

Belgium
Allergan

Completed

MDs on Botox Utility (MOBILITY)

Strabismus | Torticollis | Muscle Spasticity | Blepharospasm

Canada
AgNovos Healthcare, LLC

Recruiting

RISE - Study of the AGN1 LOEP SV Kit in Patients With Vertebral Compression Fractures

Vertebral Fracture | Vertebral Compression Fracture | Vertebral Compression

Germany, Spain
AgNovos Healthcare, LLC

Recruiting

EXTENSION - Long-term Follow-up Study of Patients Treated With AGN1 LOEP

Osteoporosis

Belgium
Allergan

Completed

Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia (GEMINI 1)

Presbyopia

United States
Allergan

Completed

A Study of Intraocular Pressure (IOP) Reduction in Newly Diagnosed Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Ocular Hypertension | Glaucoma, Open-Angle

Spain
Allergan

Completed

A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Were Insufficiently Responsive to Monotherapy

Ocular Hypertension | Glaucoma, Open-Angle

Spain
Allergan

Completed

A Long-Term Safety and Efficacy Study AGN-19920 in Patients With Persistent Erythema Associated With Rosacea

Erythema | Rosacea

United States
AgNovos Healthcare, LLC

Recruiting

STAND - Study of the AGN1 LOEP SV Kit Compared to PMMA in Patients With Vertebral Compression Fractures

Vertebral Compression Fracture | Vertebral Compression | Compression Fracture

United States
Allergan

Completed

Performance and Acceptance of Optive Versus Hylocomod Eyedrops in Patients With Dry Eye Symptoms

Dry Eye Syndromes

United Kingdom
Allergan

Completed

A Safety and Efficacy Study to Assess OZURDEX® in Patients With Macular Oedema Secondary to Retinal Vein Occlusion (RVO)

Macular Edema | Retinal Vein Occlusion

Germany
Allergan

Completed

Observational Study of Botulinum Toxin Type A in Patients With Urinary Incontinence Associated With Overactive Bladder (BOREAL)

Urinary Bladder, Overactive | Urinary Bladder, Neurogenic

France
Allergan

Completed

Post Market Surveillance of OZURDEX® for Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO)

Macular Edema | Retinal Vein Occlusion

Denmark, Norway, Sweden
Allergan Medical

Completed

Postmarket Study of JUVÉDERM VOLBELLA™ With Lidocaine in the Lips

Lip Augmentation

Germany
Allergan

Completed

A Retrospective Data Collection Study in Patients Receiving Dexamethasone Intravitreal Implant (Ozurdex®) for Macular Oedema Due to Retinal Vein Occlusion (RVO)

Macular Edema

Germany
Allergan

Completed

A Phase 3 Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia (GEMINI 2)

Presbyopia

United States
Allergan

Completed

AGN 201904 Versus Esomeprazole in the Prevention of Aspirin-induced Stomach or Upper Intestinal Damage in Healthy Volunteers

Peptic Ulcer

United States
Allergan

Completed

Retrospective Study of Incidence and Etiology of Reoperation After Primary Augmentation With Natrelle® Breast Implants (RANBI)

Breast Implantation

France, Spain, Germany, Israel, United Kingdom
Allergan

Completed

An Observational Study of BOTOX® for the Management of Urinary Incontinence in Patients With Idiopathic Overactive Bladder (GRACE)

Urinary Bladder, Overactive | Urinary Incontinence

United Kingdom, Germany, Spain, Sweden
Allergan

Completed

Study of Ozurdex® Treatment Practice in Patients With Macular Oedema Due to Retinal Vein Occlusion

Macular Edema | Retinal Vein Occlusion

France
Allergan

Completed

A Study of Bimatoprost 0.01% in the Clinical Setting (APPEAL-Taiwan)

Ocular Hypertension | Glaucoma, Primary Open Angle

Taiwan
Allergan Medical

Completed

The Volumizing Effect of Juvéderm VOLUMA® in the Mid-Face

Age-related Volume Deficit in the Mid-face

Belgium, Netherlands, Germany, United Kingdom
Allergan

Completed

A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma, Open-Angle

Germany, Netherlands
Allergan

Completed

Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma, Open-Angle

Switzerland
Allergan

Completed

An Observational Study of OPTIVE PLUS® for the Treatment of Dry Eye Disease

Dry Eye Syndromes

Germany
Allergan

Completed

Observational Study of Lumigan® 0.01% for Treatment of Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Ocular Hypertension | Open-Angle Glaucoma

Belgium
Allergan

Completed

Retrospective Data Collection Study in Patients Receiving Two or More OZURDEX® Injections for Macular Oedema Secondary to Retinal Vein Occlusion

Retinal Vein Occlusion | Macular Oedema

Belgium

3

Subscribe